Skip to main content

Table 1 Characteristics of patients newly diagnosed with inflammatory bowel disease (N = 350)

From: Symptoms and symptom clusters in patients newly diagnosed with inflammatory bowel disease: results from the IBSEN III Study

 

IBD

CD

UC

 

N = 350

n = 119

n = 231

Sociodemographic characteristics

 Age (mean, SD)

39.0 (14.4)

40.1 (15.4)

38.5 (13.9)

Gender, n (%)

 Female

174 (49.7)

68 (57.1)

106 (45.9)

 Male

176 (50.3)

51 (42.9)

125 (54.1)

Education, n (%)

 University; ≥2 years

177 (50.6)

57 (47.9)

120 (51.9)

 Elementary/upper secondary

173 (49.4)

62 (52.1)

111 (48.1)

Marital status, n (%)

 Married/co-inhabitant

236 (67.4)

75 (63.0)

161 (69.7)

 Single/widow(ed)

114 (32.6)

44 (37.0)

70 (30.3)

Work status, n (%)

 Working

297 (84.9)

96 (80.7)

201 (87.0)

 Not working

53 (15.1)

23 (19.3)

30 (13.0)

Clinical characteristics

Diagnosis, n (%)

 Crohn’s disease

119 (34.0)

  

 Ulcerative colitis

231 (66.0)

  

Montreal - location for CD, n (%)

 Ileal (L1)

 

61 (51.3)

 

 Colonic (L2)

 

24 (20.2)

 

 Ileocolonic (L3)

 

34 (28.6)

 

 Upper tract only or modifier (L4)a

 

2 (1.7)

 

Montreal – behavior for CD, n (%)

 Non-stricturing, non-penetrating (B1)

 

92 (77.3)

 

 Stricturing (B2)

 

25 (21.0)

 

 Penetrating (B3)

 

2 (1.7)

 

 Perianal disease (B4)a

 

10 (8.4)

 

Montreal – extent for UC, n (%)

 Ulcerative proctitis (E1)

  

94 (40.7)

 Left-sided UC (E2)

  

53 (22.9)

 Extensive UC (E3)

  

84 (36.4)

Montreal disease severity for UC, n (%)

 Clinical remission (S0)

  

4 (1.7)

 Mild UC (S1)

  

92 (39.8)

 Moderate UC (S2)

  

115 (49.8)

 Severe UC (S3)

  

20 (8.7)

 Calprotectin ≥ 250 µg/g

158 (52.0)

56 (54.4)

102 (50.7)

Missing, n (%)

46 (13.1)

  

Elevated HBI/SCCAIb, n (%)

190 (55.6)

56 (48.3)

134 (59.3)

Missing, n (%)

8 (2.3)

  

25-OH Vitamin D deficiencyc, n (%)

98 (28.2)

29 (24.6)

69 (30.1)

Missing, n (%)

3 (0.9)

  

Anemiad, n (%)

45 (12.9)

16 (13.4)

29 (12.7)

Missing, n (%)

2 (0.6)

  

Iron deficiencye, n (%)

104 (34.4)

30 (29.4)

74 (37.0)

Missing, n (%)

48 (13.8)

  

Current tobacco use, n (%)

26 (7.4)

13 (10.9)

13 (5.6)

  1. Abbreviations: CD Crohn’s disease, UC Ulcerative colitis, HBI Harvey Bradshaw Index, SCCAI Simple Clinical Colitis Index
  2. aUpper tract modifier and perianal disease coexist with other location categories
  3. bClinical disease activity score: HBI ≥ 5 for CD and SCCAI ≥ 2.5 for UC
  4. cVitamin D deficiency < 50 mmol/L
  5. dAnemia: Anemia: hemoglobin levels of < 12 g/dl for females and < 13 g/dl for men
  6. eIron Deficiency: If calprotectin < 250 µg/g and ferritin < 30 µg/L: indicative of iron deficiency and ff calprotectin ≥ 250 µg/g and ferritin < 100 µg/L
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us